ISCT Webinar: COGs Survey: Results and Red Flags
Presented by the ISCT Business Model & COGs Sub-Committee
Please open the PDF slides and click the link on the first page to access the Digital Recording.
Date: November 5th, 2013
Time: 12pm ET to 1:00pm ET
Chair: William Milligan, Chair, ISCT Business Models and COGs Subcommittee
Speaker(s): William Milligan, Robert Perry, Knut Niss, members, ISCT Business Models and COGs Subcommittee
About the Webinar:
This webinar will review the results of the ISCT COGs Survey circulated to Membership in June, 2013. The COGs Survey explored a range of considerations for cell therapy manufacturing (both autologous and allogeneic) as it relates to managing COGs (cost of goods). The goal of the survey was to gain better knowledge of current practices and experience in cell therapy manufacturing development. Understanding where cell therapy manufacturing standards are today, will help guide the drafting of a COGs white paper to provide a road map of considerations and resources for manufacturing / COGs planning and decision making. This is a key strategic discipline for developing cell therapies with the goal of optimal pricing, for broad adoption and reimbursement, leading to successful commercialization.
Join members of the ISCT Business Models and COGs subcommittee as they review the results and key learning gained from the responses. The committee will identify areas of focus for cost of goods considerations and introduce future plans for addressing the needs identified.